Bio-Rad Laboratories (BIO-B) Current Leases (2019 - 2026)

Bio-Rad Laboratories (BIO-B) has 8 years of Current Leases data on file, last reported at $36.2 million in Q1 2026.

• Quarterly Current Leases fell 12.35% year-over-year to $36.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.2 million (down 12.35% YoY) and the FY2025 annual result came in at $36.1 million, down 13.43% from the prior year.
• Current Leases was little changed at $36.2 million in Q1 2026 per BIO-B's latest filing, from $36.1 million in the prior quarter.
• Across five years, Current Leases topped out at $42.8 million in Q3 2024 and bottomed at $34.0 million in Q3 2022.
• The 5-year median for Current Leases is $36.8 million (2025), against an average of $38.3 million.
• The widest annual swing landed in 2023, when Current Leases increased 14.85%; it then dropped 14.02% in 2025.
• Tracing BIO-B's Current Leases over 5 years: stood at $36.3 million in 2022, then gained by 11.18% to $40.4 million in 2023, then grew by 3.22% to $41.7 million in 2024, then fell by 13.43% to $36.1 million in 2025, then gained by 0.28% to $36.2 million in 2026.
• Per Business Quant, the three latest BIO-B Current Leases figures stand at $36.2 million (Q1 2026), $36.1 million (Q4 2025), and $36.8 million (Q3 2025).

Peer Comparison